Compounded Semaglutide San Antonio: A Guide

Yoga by a lake

How Semaglutide Works

Compounded Semaglutide San Antonio: Semaglutide works by acting like a hormone in the body called GLP-1 (glucagon-like peptide-1). Your body usually releases this hormone after you eat. It helps lower blood sugar by releasing more insulin, slowing digestion, and reducing sugar production in the liver. Because it also affects appetite, it can help people eat less and lose weight.

Over time there have been several versions of these GLP-1 medicines. Patients have used them long term for treating diabetes. Later versions have been increasingly successful in helping patients achieve their A1c goals, but also weight loss goals.

Semaglutide is not known to cause low blood sugar which is why non-diabetics can safely take the medicine. If someone’s blood sugar is normal to start with, they usually won’t have low blood sugar from taking the medicine.

The results are not permanent. If you do not maintain appropriate lifestyle changes, you can easily regain weight and high sugar levels. Doctors have prescribed semaglutide to patients for years and continue to evaluate its safety. Our providers at Magnolia Well have years of experience prescribing semaglutide San Antonio and achieving excellent results.

Brands

Several brand names market semaglutide, each tailored for different medical conditions and modes of administration.

  • Novo Nordisk introduced Ozempic in 2017, and doctors primarily use it for managing type 2 diabetes. It is administered via injection.
  • Rybelsus is the first oral GLP-1 treatment for type 2 diabetes, approved by the FDA in 2019.
  • Wegovy: Launched in 2021, Wegovy is specifically approved for chronic weight management.
orange pills in a palm
Semaglutide San Antonio

Market Reception and Usage

Ozempic is popular with healthcare providers. It is injected once a week at home. It helps reduce the risk of heart problems.

Similarly, Rybelsus has filled a significant gap for those preferring oral medication with diabetics only. Wegovy, on the other hand, addresses the growing need for effective long-term obesity management solutions in the market.

These products help diabetic patients and healthcare providers manage diabetes and weight. They are important tools for improving care for people with these chronic conditions.

Recent Research, Benefits, and Health Effects of Weight Loss

New studies, like the ones in JAMA, show that Semaglutide can do more than just control blood sugar and weight. It can lower heart disease risk and protect the kidneys, which often affect people with diabetes. Semaglutide can reduce the risk of heart attacks and strokes in people with type 2 diabetes and heart disease (JAMA, 2021). Contextualizing Risk Among Patients With Heart Failure | Cardiology | JAMA | JAMA Network

In terms of renal health, Semaglutide can slow the progression of kidney disease in diabetic patients. Diabetes greatly increases the risk of developing kidney disease. This can lead to the need for dialysis or a kidney transplant if it advances to kidney failure. Protection against kidney disease is important because of this.

Weight Loss and Overall Health Benefits

The benefits of weight loss with Semaglutide are extensive and influence various aspects of health, enhancing the quality of life for patients:

  • Blood Sugar Regulation: Effective management of blood glucose levels is a cornerstone of diabetes treatment, and weight loss can improve insulin sensitivity.
  • Chronic Pain Reduction: Excess weight often exacerbates joint pain and can contribute to the development of chronic pain conditions; losing weight can significantly alleviate these symptoms.
  • Improved Lung Health: Weight loss has been linked to decreased severity of sleep apnea and other lung issues that often accompany obesity.
  • Heart Health: Apart from direct effects on heart disease risks, weight loss can lower blood pressure and improve cholesterol levels, further protecting the cardiac system.
people doing yoga by a lake
Semaglutide San Antonio

Semaglutide as an Alternative to Weight Loss Surgery

Traditionally, weight loss surgery has been viewed as a last resort for those who have significant amounts of weight to lose and have not succeeded with other methods. However, Semaglutide offers a non-surgical alternative that can achieve substantial weight loss outcomes. Unlike surgical interventions, which come with higher risks and require significant recovery time, Semaglutide is administered through injections and has a low risk profile.

The effectiveness of Semaglutide in promoting weight loss and its ability to improve various metabolic markers make it a compelling alternative to more invasive procedures like gastric bypass or sleeve gastrectomy. For many patients, this drug provides a viable path to weight loss that doesn’t require the financial, physical, and emotional costs associated with surgery.

Challenges in Patient Access

Semaglutide, a medication approved for diabetes and weight loss, has garnered attention not only for its efficacy but also for its high cost and supply challenges. Here’s a breakdown of why it’s expensive, why it can be hard for patients to get, and how compounding pharmacies play a role in making it more accessible:

  • High Demand: There is a high demand for Semaglutide among both diabetic and non-diabetic patients, which can strain supply chains. Mounjaro has similar high demand because of its effectiveness.
  • Prior Authorizations: These typically are very burdensome for clinicians to fill out and require patients try other medicines (usually less expensive ones) prior to having more expensive medicines covered. Clinicians learn to avoid these medicines as they will likely be denied or ultimately expensive anyway.
  • Complex Dosing/Titrations: Semaglutide involves several dosages and titration steps that can be difficult to manage. This complexity can lead to supply challenges, as different dosages may be in varying demand.
  • Restarting Treatment: When someone has to discontinue Semaglutide due to supply issues, they may need to start again at the lowest dose, which can disrupt treatment efficacy and patient progress.
  • Limited Suppliers: There is only one major supplier for the brand-name versions of this medicine, which can lead to monopolies and contribute to supply shortages.

Compounding pharmacies help mitigate some of these challenges by providing customized dosages that adapt more flexibly to the available supply and patient needs. Semaglutide in San Antonio has faced significant shortages leading to therapeutic challenges in Ozempic and Wegovy patients.

Semaglutide Dosing Regimen

This medicine typically begins at a low dose to minimize side effects and we allow patients to adjust gradually. The starting dose is often 0.25 mg once weekly. Patients stay at this dose, and the other doses for a total of 4 weeks before graduating to the higher dose.

The subsequent doses are: 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg, all once weekly. The dosage may be increased gradually over time, depending on individual patient response and treatment goals.

Sometimes patients start Semaglutide therapy but become disheartened because it seems not to work. Primary care physicians may not be helping their patients when they only prescribe a low dose of a medication. They may never increase the dosage.

They often just refill the medication without adjusting the dosage. Not losing weight on a low dose of Semaglutide doesn’t mean therapy has failed for a patient. Understanding this is crucial.

Compounded Semaglutide San Antonio

Providers at Magnolia Well have goal to prescribe Compounded Semaglutide in San Antonio to patients with maximum tolerated dosages, only as patients can tolerate.

Schedule An Appointment

Speak with a doctor today.
Scroll to Top

To be eligible for services you must be 18+ and live in Texas